2022 ESC – Data From REDUCE-IT Trial
Dr. Michael Miller, MD, FACC, FAHA, Chief of Medicine at the Corporal Michael J. Crescenz VA Medical Center in Philadelphia discusses new data from the REDUCE-IT study, which were presented at a late-breaking scientific session at the European Society of Cardiology (ESC) congress, on VASCEPA ®/VAZKEPA ® (icosapent ethyl) in patients with cardiovascular disease and in another study, with patients who smoke.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Healthcare. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Healthcare and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Healthcare?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Key Takeaways
- Key Point: Michael Miller, MD, FACC, FAHA, Chief of Medicine at the Corporal Michael J.
- Key Point: Crescenz VA Medical Center in Philadelphia discusses new data from the REDUCE-IT study, which were presented at a late-breaking scientific session at the European Society of…
- Key Point: His major research interests are disorders of lipid and lipoprotein metabolism, molecular studies of HDL cholesterol, triglycerides and the postprandial response to dietary fat,…
- Healthcare Insight: Stay informed with the latest healthcare news and developments from Health Professional Radio.
- Healthcare Insight: Stay informed with the latest healthcare news and developments from Health Professional Radio.
Michael Miller, MD, FACC, FAHA is Professor of Cardiovascular Medicine, Epidemiology & Public Health at the University of Maryland School of Medicine in Baltimore, MD. His major research interests are disorders of lipid and lipoprotein metabolism, molecular studies of HDL cholesterol, triglycerides and the postprandial response to dietary fat, nontraditional coronary risk factors and clinical
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.


